111 related articles for article (PubMed ID: 1695018)
1. The incorporation of 5-fluorouracil into rat liver tumor and normal tissues after administration by the hepatic artery during temporary portal vein clamping.
el Hag IA; Jakobsson B; Jönsson PE; Stenram U
Res Exp Med (Berl); 1990; 190(3):183-92. PubMed ID: 1695018
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of 5-fluorouracil into rat liver tumor and normal tissues and the liver nucleotide profile after administration by the hepatic artery during portal venous branch ligation.
Jakobsson B; Roos G; el Hag IA; Jönsson PE; Stenram U
Res Exp Med (Berl); 1992; 192(1):13-21. PubMed ID: 1570410
[TBL] [Abstract][Full Text] [Related]
3. Interferon and the incorporation of 5-fluorouracil into RNA of normal tissues and a secondary liver carcinoma in rat.
Roos G; Stenram U
Anticancer Res; 1994; 14(2A):379-82. PubMed ID: 7517119
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.
Jakobsson B; el Hag IA; Erichsen C; Christensson PI; Jönsson PE; Stenram U
Anticancer Res; 1989; 9(2):285-90. PubMed ID: 2751255
[TBL] [Abstract][Full Text] [Related]
5. Superiority of hepatic arterial infusion in preventing catabolism of 5-FU compared with portal vein infusion revealed by an in vivo 19F NMR study.
Okuno K; Hirai N; Lee YS; Tarabar D; Ueno H; Yasutomi M
Cancer Chemother Pharmacol; 1998; 42(4):341-4. PubMed ID: 9744781
[TBL] [Abstract][Full Text] [Related]
6. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of 5-fluorouracil into RNA of normal tissues and an adenocarcinoma in protein-deprived rats.
el Hag IA; Jakobsson B; Erichsen C; Christensson PI; Jönsson PE; Stenram U
In Vivo; 1987; 1(4):215-20. PubMed ID: 2485132
[TBL] [Abstract][Full Text] [Related]
8. Tumor and liver drug uptake following hepatic artery and portal vein infusion.
Sigurdson ER; Ridge JA; Kemeny N; Daly JM
J Clin Oncol; 1987 Nov; 5(11):1836-40. PubMed ID: 3681370
[TBL] [Abstract][Full Text] [Related]
9. Relation between the incorporation of 5-fluorouracil into liver carcinoma and normal tissue RNA at hepatic arterial administration in the rat is altered by overnight starvation.
Roos G; Stenram U
J Surg Oncol; 1993 Aug; 53(4):231-4. PubMed ID: 7688058
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil incorporation into RNA of a rat liver adenocarcinoma after hepatic artery injection together with degradable starch microspheres.
Teder H; Erichsen C; Christensson PI; Jönsson PE; Stenram U
Cancer Drug Deliv; 1987; 4(3):169-76. PubMed ID: 2453264
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
12. Modulation of 5-fluorouracil metabolism by thymidine. In vivo and in vitro studies on RNA-directed effects in rat liver and hepatoma.
Engelbrecht C; Ljungquist I; Lewan L; Yngner T
Biochem Pharmacol; 1984 Mar; 33(5):745-50. PubMed ID: 6201174
[TBL] [Abstract][Full Text] [Related]
13. Effects of dosage and infusion time on the incorporation of 5-fluorouracil into DNA and RNA of normal tissues and an adenocarcinoma transplanted to rat liver.
Erichsen C; Christensson PI; Jacobsson B; Jönsson PE; Stenram U
J Surg Oncol; 1988 Jul; 38(3):155-9. PubMed ID: 2455851
[TBL] [Abstract][Full Text] [Related]
14. RNA labelling with 3H-orotic acid and 3H-fluorouracil of rat liver tumour following transient hepatic arterial ischaemia.
Mack P; Tranberg KG; Strenram U; Jeppsson B; Widlus D; Bengmark S
Eur J Surg Oncol; 1988 Dec; 14(6):669-75. PubMed ID: 3192004
[TBL] [Abstract][Full Text] [Related]
15. Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases.
Archer SG; Gray BN
Am J Surg; 1990 Mar; 159(3):325-9. PubMed ID: 2305941
[TBL] [Abstract][Full Text] [Related]
16. Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin and RSU-1069.
Roos G; Christensson PI; el Hag IA; Jakobsson B; Teder H; Stenram U
Anticancer Res; 1993; 13(3):635-41. PubMed ID: 8317891
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases.
Archer S; Gray B
Surgery; 1990 Sep; 108(3):502-7. PubMed ID: 2396194
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of 5-fluorouracil into hepatoma and normal tissue RNA at protein depletion in the rat.
Roos G; Stenram U
J Surg Oncol; 1997 Jul; 65(3):155-8. PubMed ID: 9236922
[TBL] [Abstract][Full Text] [Related]
19. Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model.
Flowerdew AD; Richards HK; Taylor I
Gut; 1987 Oct; 28(10):1201-7. PubMed ID: 3678948
[TBL] [Abstract][Full Text] [Related]
20. Moment analysis of intestinal first-pass metabolism by portal-systemic concentration difference in single conscious rat using 5'-deoxy-5-fluorouridine and 5-fluorouracil as model drug system.
Sawai Y; Yamaoka K; Takemura A; Nakagawa T
J Pharm Sci; 1997 Nov; 86(11):1269-72. PubMed ID: 9383738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
